These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1526077)

  • 1. Intravenous nicotine retards transdermal absorption of nicotine: evidence of blood flow--limited percutaneous absorption.
    Benowitz NL; Jacob P; Olsson P; Johansson CJ
    Clin Pharmacol Ther; 1992 Sep; 52(3):223-30. PubMed ID: 1526077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and absorption kinetics of nicotine following application of a transdermal system.
    Gupta SK; Benowitz NL; Jacob P; Rolf CN; Gorsline J
    Br J Clin Pharmacol; 1993 Sep; 36(3):221-7. PubMed ID: 9114908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic disposition of multiple-dose transdermal nicotine in healthy adult smokers.
    Kochak GM; Sun JX; Choi RL; Piraino AJ
    Pharm Res; 1992 Nov; 9(11):1451-5. PubMed ID: 1475232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable isotope method for studying transdermal drug absorption: the nicotine patch.
    Benowitz NL; Chan K; Denaro CP; Jacob P
    Clin Pharmacol Ther; 1991 Sep; 50(3):286-93. PubMed ID: 1914363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Temperature-Dependent Dermal Absorption and Clearance for Transdermal and Topical Drug Applications.
    LaCount TD; Zhang Q; Hao J; Ghosh P; Raney SG; Talattof A; Kasting GB; Li SK
    AAPS J; 2020 May; 22(3):70. PubMed ID: 32390069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel prolonged-release nicotine transdermal patch.
    Davaran S; Rashidi MR; Khandaghi R; Hashemi M
    Pharmacol Res; 2005 Mar; 51(3):233-7. PubMed ID: 15661573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
    Panda A; Sharma PK; Narasimha Murthy S
    AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine-mecamylamine interactions.
    Zevin S; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro comparative studies of two marketed transdermal nicotine delivery systems: Nicopatch and Nicorette.
    Olivier JC; Rabouan S; Couet W
    Int J Pharm; 2003 Feb; 252(1-2):133-40. PubMed ID: 12550788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Modelling of Transdermal and Systemic Kinetics of Topically Applied Solutes: Model Development and Initial Validation for Transdermal Nicotine.
    Chen T; Lian G; Kattou P
    Pharm Res; 2016 Jul; 33(7):1602-14. PubMed ID: 26956458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-related cardiovascular and endocrine effects of transdermal nicotine.
    Zevin S; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 1998 Jul; 64(1):87-95. PubMed ID: 9695723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state pharmacokinetics and dose relationship of nicotine delivered from Nicoderm (Nicotine Transdermal System).
    Gorsline J; Gupta SK; Dye D; Rolf CN
    J Clin Pharmacol; 1993 Feb; 33(2):161-8. PubMed ID: 8440766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).
    Gupta SK; Okerholm RA; Coen P; Prather RD; Gorsline J
    J Clin Pharmacol; 1993 Feb; 33(2):169-74. PubMed ID: 8440767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch.
    Linakis MW; Rower JE; Roberts JK; Miller EI; Wilkins DG; Sherwin CMT
    Br J Clin Pharmacol; 2017 Dec; 83(12):2709-2717. PubMed ID: 28771779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of plasma nicotine concentrations after application of nicoderm (nicotine transdermal system) to different skin sites.
    Gorsline J; Okerholm RA; Rolf CN; Moos CD; Hwang SS
    J Clin Pharmacol; 1992 Jun; 32(6):576-81. PubMed ID: 1634647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of transdermal therapeutics in perioperative care].
    Gentile A; Tran-Van D; Dardare E; Fritsch N; Benois A; Fontaine B
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):311-20. PubMed ID: 19304449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute effects of daily nicotine intake on heart rate--a toxicokinetic and toxicodynamic modelling study.
    Gajewska M; Worth A; Urani C; Briesen H; Schramm KW
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):312-24. PubMed ID: 25066669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Heat Effects on Transdermal Nicotine Delivery In Vitro and In Silico Using Heat-Enhanced Transport Model Analysis.
    La Count TD; Zhang Q; Murawsky M; Hao J; Ghosh P; Dave K; Raney SG; Talattof A; Kasting GB; Li SK
    AAPS J; 2020 Jun; 22(4):82. PubMed ID: 32488395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of application sites and multiple doses on nicotine pharmacokinetics in healthy male Japanese smokers following application of the transdermal nicotine patch.
    Sobue S; Sekiguchi K; Kikkawa H; Irie S
    J Clin Pharmacol; 2005 Dec; 45(12):1391-9. PubMed ID: 16291714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.